¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"refractory anemia with excess blasts"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® anemia ÇÑ±Û ºóÇ÷
¼³¸í   
  Ç÷¾×ÀÌ ¼øÈ¯Çϴ ¸ñÀû Áß¿¡¼­ °¡Àå Áß¿äÇÑ °ÍÀº ¿©·¯ °¡Áö ¿µ¾ç¼Ò¸¦ ¸»ÃÊÀÇ Àå±â·Î º¸±ÞÇÏ°í ¸»ÃÊÀÇ Àå±â¿¡¼­ ³ª¿À´Â ¿©·¯ ³ëÆó¹°À» ÄáÆÏÀ̳ª Æó·Î º¸³» ¹è¼³¹°À» Ã³¸®Çϴ µ¥ ÀÖ´Ù. ±× Áß¿¡¼­ »ê¼ÒÀÇ ¿î¹ÝÀº °¡Àå Áß¿äÇѵ¥ ¹Ù·Î ÀÌ »ê¼ÒÀÇ ¿î¹ÝÀ» ´ã´çÇϴ °ÍÀÌ ÀûÇ÷±¸ÀÌ´Ù. ÀûÇ÷±¸¿¡´Â Ç÷»ö¼Ò¶ó´Â ¹°ÁúÀÌ ÀÖ¾î À̰ÍÀÌ »ê¼Ò¿Í °áÇÕÇÏ¿© »ê¼Ò¸¦ ¸»ÃÊÀÇ Àå±â·Î ¿î¹ÝÇÒ ¼ö°¡ ÀÖ´Ù.
  
  ºóÇ÷À̶õ ´ÜÀ§ºÎÇÇÀÇ Ç÷¾×¼Ó¿¡ ÀûÇ÷±¸ÀÇ ¾çÀÌ ÀûÀº °æ¿ì¸¦ ¸»ÇÑ´Ù. ÀûÇ÷±¸ÀÇ ¾çÀ» ³ªÅ¸³»´Â °ÍÀ¸·Î´Â 3°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀûÇ÷±¸ÀÇ ¼ýÀÚ¸¦ Á÷Á¢ Ç¥ÇöÇϴ ¹æ¹ý°ú, Ç÷»ö¼ÒÀÇ ¾çÀ» Á¤·®ÇÏ¿© ±× ¾çÀ» Ç¥½ÃÇϴ ¹æ¹ý°ú, Ç÷¾×¼Ó¿¡¼­ ÀûÇ÷±¸°¡ Â÷ÁöÇϴ ¾ç(ÀûÇ÷±¸µîÀûÀ²)À» ³ªÅ¸³»´Â ¹æ¹ýÀÌ ±×°ÍÀÌ´Ù. ´ë°³ ºóÇ÷À̶ó ÇÔÀº ³²¼º¿¡¼­ Ç÷»ö¼Ò < 14g/dl, Ç÷»ö¼Ò < 42%, ÀûÇ÷±¸ÀÇ ¼ö < 4,000,000/mm3ÀÏ °æ¿ìÀ̰í, ¿©¼º¿¡¼± Ç÷»ö¼Ò < 12g/dl, Ç÷»ö¼Ò < 36%, ÀûÇ÷±¸ÀÇ ¼ö < 3,300,000/mm3ÀÏ °æ¿ì¸¦ ÁöĪÇÑ´Ù.
¿µ¹® pernicious anemia ÇÑ±Û ¾Ç¼ººóÇ÷
¼³¸í   
  ¾Ç¼º(»ý¸íÀ» À§ÇùÇϸç, Ä¡·á¿¡ ÀúÇ×Çϴ °æ¿ì¿¡ ´ë°³ ¾Ç¼ºÀ̶ó ºÎ¸§. ¿¹¸¦ µé¾î ÁøÇàµÈ ¾ÏÀÇ °æ¿ì)À̶ó À̸§ºÙ¾î ÀÖÁö¸¸, ½ÇÁ¦ÀûÀ¸·Î´Â ¾Ç¼ºÀÌ ¾Æ´Ï´Ù. ºóÇ÷ÀÇ ÀÏÁ¾ÀÌ´Ù. Á¤»óÀûÀ¸·Î ÀûÇ÷±¸´Â ¹ß´Þ°ú ¼º¼÷°úÁ¤¿¡¼­ ºñŸ¹Î B12°¡ ÇʼöÀûÀÌ´Ù. ÀÌ ºñŸ¹Î B12ÀÇ Ç÷Áß³óµµ°¨¼Ò¿¡ ÀÇÇØ ÀûÇ÷±¸»ý¼º¿¡ ÁöÀåÀ» °¡Á®¿À°Ô µÇ°í, Ç÷¾×³»¿¡ Æ¯Â¡ÀûÀΠ°Å´ëÀû¸ð±¸(megaloblast)ÀÇ Çü¼ºÀÌ ³ªÅ¸³ª´Â Áúº´À» ¸»ÇÑ´Ù.
¿µ¹® hemolytic anemia ÇÑ±Û ¿ëÇ÷ºóÇ÷
¼³¸í   
  ¿ëÇ÷ºóÇ÷À̶õ ÀûÇ÷±¸ÀÇ °úµµÇÑ ÆÄ±«¿¡ ÀÇÇÑ ºóÇ÷ÀÌ´Ù. ¿ø·¡ 120ÀÏ Á¤µµÀÇ ¼ö¸íÀ» °¡Áö´Â ÀûÇ÷±¸ÀÇ ¼ö¸íÀ̠ª¾ÆÁö´Â °ÍÀÌ´Ù. ¿©±â¿¡´Â ¿©·¯ °¡Áö ¿øÀÎÀÌ ÀÖÀ» ¼ö°¡ Àִµ¥ ´ëÇ¥ÀûÀΠ¿øÀÎÀ¸·Î´Â ÀûÇ÷±¸¿¡ ´ëÇÑ Ç×ü°¡ »ý±â´Â °Í(¹ßÀÛ¼º¾ß°£Ç÷»ö¼Ò´¢Áõ)°ú ÀûÇ÷±¸ÀÚüÀÇ ÀÌ»ó(À¯Àü¼ºµÕ±ÙÀûÇ÷±¸Áõ), ±×¸®°í ´Ù¸¥ Áúº´¿¡ ÀÇÇØ¼­ 2Â÷ÀûÀ¸·Î »ý±â´Â °ÍÀÌ ÀÖ´Ù.
¿µ¹® aplastic anemia ÇÑ±Û Àç»ýºÒ·®ºóÇ÷
¼³¸í   
  Àç»ýºÒ·®¼º ºóÇ÷À̶õ °ñ¼öÀÇ ÀÌ»óÀ¸·Î »ý±â´Â ºóÇ÷ÀÌ´Ù. °ñ¼ö¶õ »À¼Ó¿¡ Á¸ÀçÇϴ °ÍÀ¸·Î Ç÷±¸¸¦ »ý¼ºÇϴ ¼¼Æ÷µé°ú ¹Ì¼º¼÷ÇÑ Ç÷±¸µé·Î ÀÌ·ç¾îÁ® ÀÖ´Ù. À̰͵éÀÌ ¿©·¯ °¡Áö ¿øÀο¡ ÀÇÇØ¼­ ÆÄ±«µÇ¾úÀ» ¶§ »ý±â´Â ºóÇ÷À» Àç»ýºÒ·®ºóÇ÷À̶ó°í ÇÑ´Ù. ±×·¯¹Ç·Î ÀûÇ÷±¸¸¸ÀÇ °¨¼Ò°¡ ¾Æ´Ï¶ó ¸ðµç Ç÷±¸ ¼¼Æ÷ÀÇ °¨¼Ò¸¦ º¼ ¼ö ÀÖ´Ù. Ä¡·á·Î´Â Ç÷±¸ »ý¼ºÀ» ÀÚ±ØÇϴ ȣ¸£¸óÀ» Åõ¿©Çϴ °ÍÀÌ ÀÖÁö¸¸ À̰ÍÀ¸·Î´Â ÆÄ±«µÈ Ç÷±¸¸¦ »ý¼ºÇϴ ¼¼Æ÷ÀÇ Àç»ýÀÌ ÀϾÁö ¸øÇϹǷΠ¿ÏÀüÇÑ Ä¡·á¶ó°í´Â º¼ ¼ö°¡ ¾ø´Ù. ¿ÏÀüÇÑ Ä¡·á·Î´Â ³²ÀÇ °ñ¼ö¸¦ Ã¤ÃëÇØ¼­ À̰Ϳ¡¼­ºÎÅÍ Ç÷±¸¸¦ »ý¼ºÇϴ ¼¼Æ÷¸¦ ºÐ¸®, È¯ÀÚ¿¡°Ô À̽ÄÇϴ °ñ¼öÀ̽ÄÀÌ ÀÖ´Ù.
¿µ¹® iron deficiency anemia ÇÑ±Û Ã¶°áÇ̺óÇ÷
¼³¸í   
  ÀûÇ÷±¸ÀÇ ±â´ÉÀº »ê¼Ò¸¦ ¿î¹ÝÇϴµ¥ ÀÖ´Ù. ÀûÇ÷±¸ ¼Ó¿¡ »ê¼Ò¿Í °áÇÕÀ» ÇÏ¿© »ê¼Ò¸¦ ¿î¹ÝÇϴ Ç÷»ö¼Ò¶ó´Â ¹°ÁúÀÌ ÀÖ´Ù. Ã¶Àº ÀÌ Ç÷»ö¼ÒÀÇ Áß¿äÇÑ ºÎºÐÀ» ÀÌ·ç´Â °ÍÀ¸·Î Ã¶ÀÌ ¾øÀ¸¸é Ç÷»ö¼Ò°¡ ¸¸µé¾îÁú ¼ö°¡ ¾ø´Ù. Ç÷»ö¼Ò°¡ ¾øÀ¸¸é ¿ª½Ã ÀûÇ÷±¸µµ ¸¸µé¾îÁöÁö ¾ÊÀ¸¹Ç·Î Ã¼³»¿¡ Ã¶ÀÌ ºÎÁ·Çϸ頺óÇ÷ÀÌ »ý±ä´Ù. À̠ö°áÇ̼º ºóÇ÷Àº ºóÇ÷ÀÇ ¿øÀΠÁß¿¡¼­ °¡Àå ÈçÇÑ °ÍÀÌ´Ù(¾à 25%¸¦ Â÷ÁöÇÑ´Ù). Ã¶ÀúÀå·®ÀÇ ÀúÇÏ-°áÇÌ, Ç÷ûö³óµµÀÇ ÀúÇÏ, Æ®¶õ½ºÆä¸°·® »ó½Â, Æ®¶õ½ºÆä¸°Æ÷È­µµÀÇ ÀúÇÏ, Ç÷»ö¼Ò³óµµ ¶Ç´Â Ç츶ÅäÅ©¸®Æ®ÀÇ ÀúÇÏ, Àú»ö¼Ò¼º´ëÀûÇ÷±¸¸¦ Æ¯Â¡À¸·Î Çϴ ºóÇ÷·Î¼­, »ýü ³»¿¡¼­ Ã¶ÀÌ Àå±â¿¡ °ÉÃÄ °áÇ̵Ǹ砱נ¶§¹®¿¡ Ç÷»ö¼Ò »ý»ê °¨¼Ò¿¡ ÀÇÇØ ÀϾ´Ù. Ã¢ÀÚ¿¡¼­ÀǠöÈí¼ö·® ºÎÁ·, Ã¶ÀÇ ¼ö¿ä Áõ´ë(À¯¾Æ±â, »çÃá±â, ÀÓ½Å), Ã¶¼Ò½Ç°úÀ×(ÃâÇ÷)¿¡ ÀÇÇØ ÀϾ¸ç, Æ¯È÷ »çÃá±â¿¡¼­ Æó°æ±â±îÁöÀÇ ¿©¼º¿¡°Ô ¸¹´Ù. Áõ»óÀ¸·Î¼­´Â ¾ó±¼Ã¢¹é, ÇǷΰ¨, ÇǺÎâ¹é, ¼ÕÅé º¯È­(½ºÇ¬ ¸ð¾ç) µîÀ» ³ªÅ¸³½´Ù. ±¸°­ ¿µ¿ª¿¡¼­´Â ÇôÀÇ Á¢ÃËÅë, ¹ßÀû, °ÇÁ¶°¨, »ïÅ´°ï¶õÀ» ¼ö¹ÝÇϸé Ç÷¯¸Ó-ºó½¼(Plummer-Vinson)ÁõÈıºÀ̶ó°í ÇÑ´Ù. Ç÷¾× ¼Ò°ßÀº Ç÷ûöÀº ÀúÇÏÇϸç, Ã¶°áÇÕ´É·ÂÀÇ »ó½Â, Àú»ö¼Ò¼º ÀÛÀºÀûÇ÷±¸¼ºÀ» ³ªÅ¸³½´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • refractory normoblastic anemia
    ³­Ä¡¼ºÁ¤»óÀûÇ÷¸ð±¸ºóÇ÷
  • absolute refractory period
    Àý´ëºÒÀÀ±â
  • functional refractory period
    ±â´ÉÀûºÒÀÀ±â
  • refractory
    1. ºÒÀÀ-, ¹«¹ÝÀÀ¼º- 2. Ä¡·áÀúÇ×¼º-, ³­Ä¡¼º-
  • refractory investment
    ³»È­¸Å¸ôÁ¦
  • refractory period
    ºÒÀÀ±â
  • refractory rickets
    ºñŸ¹ÎDºÒÀÀ±¸·çº´, ºÒÀÀ¼º±¸·çº´
  • refractory state
    ºÒÀÀ»óÅÂ
  • relative refractory period
    »ó´ëºÒÀÀ±â
  • antibody excess
    Ç×ü°úÀ×
  • antibody excess zone
    Ç×ü°úÀ×±¸¿ª
  • antigen excess
    Ç׿ø°úÀ×
  • antigen excess zone
    Ç׿ø°úÀ×±¸¿ª
  • accommodative excess
    Á¶Àý°ú´Ù
  • base excess
    ¿°±â°úÀ×
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • excess
    °ú´Ù, °úÀ×
  • antigen excess
    Ç׿ø°úÀ×
  • refractory period
    ºÒÀÀ±â
  • refractory state
    ¹«¹ÝÀÀ»óÅÂ
  • anemia of chronic disease
    ¸¸¼ºº´ºóÇ÷
  • anemia
    ºóÇ÷
  • aplastic anemia
    Àç»ýºÒ·®ºóÇ÷, ¹«Çü¼ººóÇ÷
  • fetal anemia
    žƺóÇ÷
  • hemolytic anemia
    ¿ëÇ÷ºóÇ÷
  • iron deficiency anemia
    ö°áÇ̺óÇ÷
  • macrocytic anemia
    Å«ÀûÇ÷±¸ºóÇ÷
  • megaloblastic anemia
    °Å´ëÀûÇ÷¸ð±¸ºóÇ÷
  • pernicious anemia
    ¾Ç¼ººóÇ÷
  • sickle cell anemia
    ³´ÀûÇ÷±¸ºóÇ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • normoblastic refractory anemia
    Á¤»óÀûÇ÷¸ð±¸Áö¿¬¹ÝÀÀºóÇ÷
  • absolute refractory period
    Àý´ëºÒÀÀ±â
  • functional refractory period
    ±â´ÉÀûºÒÀÀ±â
  • refractory investment
    ³»È­¸Å¸ôÁ¦
  • platelet immunologic refractory state
    Ç÷¼ÒÆÇ¸é¿ªºÒÀÀ»óÅÂ
  • refractory period
    ºÒÀÀ±â
  • relative refractory period
    »ó´ëºÒÀÀ±â
  • refractory rickets
    (¢¡vitamin D-resistant rickets) ºñŸ¹ÎµðÀúÇ×±¸·íº´
  • refractory state
    ¹«¹ÝÀÀ»óÅÂ
  • accommodative excess
    Á¶Àý°ú´Ù
  • antibody excess
    Ç×ü°úÀ×
  • antibody excess zone
    Ç×ü°úÀ×±¸¿ª
  • antigen excess
    Ç׿ø°úÀ×
  • antigen excess zone
    Ç׿ø°úÀ×±¸¿ª
  • base excess
    ¿°±â°úÀ×
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • refractory megaloblastic anemia
    Ç×Ä¡·á¼º°ÅÀû¾Æ±¸ºóÇ÷(ùñö½èþàõËÝîåä´Ï¹Þ¸ úì).
  • refractory megaloblastic anemia
    Ç×Ä¡·á¼º°ÅÀû¾Æ±¸ºóÇ÷(ùñö½èþàõËÝîåä´Ï¹Þ¸úì)
  • refractory sideroblastic anemia
    ºÒÀÀ¼ºÃ¶Àû¸ð±¸ºóÇ÷
  • accommodative excess
    Á¶Àý°ú´Ù
  • antibody excess
    Ç×ü°úÀ×(ù÷ô÷Φí¥).
  • antibody excess zone
    Ç×ü°úÀ×´ë(ù÷ô÷Φí¥Óá).
  • antibody excess zone
    Ç×ü°úÀ×´ë(ù÷ô÷Φí¥Óá).
  • antibody excess zone
    Ç×ü°úÀ×´ë(ù÷ô÷Φí¥Óá).
  • antigen excess
    Ç׿ø°ú´Ù(ù÷ê«Î¦Òý).
  • antigen excess zone
    Ç׿ø°úÀ×´ë.
  • antigen excess zone
    Ç׿ø°úÀ×´ë.
  • antigen excess zone
    Ç׿ø°úÀ×´ë.
  • absolute refractory period
    Àý´ëºÒÀÀ±â(¡­ÝÕëëÑ¢)
  • histamin refractory
    È÷½ºÅ¸¹Î¹«¹ÝÀÀ¼º(¡­ÙíÚãëëàõ)ÀÇ.
  • platelet immunologic refractory state
    Ç÷¼ÒÆÇ¸é¿ªÇÐÀû ºÒÀÀ»óÅÂ(ÝÕëëßÒ÷¾)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • refractory anemia with excess blasts
    ¸ð¼¼Æ÷°ú´Ù¼º ºÒÀÀ¼ººóÇ÷
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • refractory anemia with excess blast =RAEB
    ¸ð¼¼Æ÷°ú´ÙºÒÀÀ¼ººóÇ÷
  • normoblastic refractory anemia
    À̸Ï(Ç÷¾×)Á¤Àû¸ð±¸¼º ºÒÀÀ¼º ºóÇ÷(ïáîåٽϹàõÝÕëëàõÞ¸ úì).
  • refractory anemia
    ºÒÀÀ¼º ºóÇ÷
  • refractory anemia
    ºÒÀÀ¼º ºóÇ÷(ÝÕëëàõÞ¸úì).
  • refractory anemia
    ºÒÀÀ¼º ºóÇ÷(ÝÕëëàõÞ¸úì)
  • refractory anemia relapsing polychondroritis
  • refractory anemia with ring sideroblast
    ȯ»óöÀû¸ð±¸(ü»ßÒôÑîåٽϹ)¼º ºÒÀÀ¼ººóÇ÷
  • refractory megaloblastic anemia
    Ç×Ä¡·á¼º°ÅÀû¾Æ±¸ºóÇ÷(ùñö½èþàõËÝîåä´Ï¹Þ¸ úì).
  • refractory megaloblastic anemia
    Ç×Ä¡·á¼º°ÅÀû¾Æ±¸ºóÇ÷(ùñö½èþàõËÝîåä´Ï¹Þ¸úì)
  • refractory sideroblastic anemia
    ºÒÀÀ¼ºÃ¶Àû¸ð±¸ºóÇ÷
  • sideroblastic refractory anemia
    öÀû¸ð±¸¼º ºÒÀÀ¼º ºóÇ÷(Ì§ËøËÎË´ËÛËÓËôËÛ Ë×Ì´).
  • sideroblastic refractory anemia
    öÀû¸ð±¸¼º ºÒÀÀ¼º ºóÇ÷(ôÑîåٽϹàõÝÕëëàõ Þ¸úì).
  • sideroblastic refractory anemia
    öÀû¸ð±¸¼º ºÒÀÀ¼º ºóÇ÷(ôÑîåٽϹàõÝÕëëàõ Þ¸úì)
  • absolute refractory period
    Àý´ëºÒÀÀ±â(¡­ÝÕëëÑ¢)
  • histamin refractory
    È÷½ºÅ¸¹Î¹«¹ÝÀÀ¼º(¡­ÙíÚãëëàõ)ÀÇ.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Immune cause (Hemolytic anemia)
    ¸é¿ª¿øÀÎ(¿ëÇ÷¼ººóÇ÷)
    [¿¾ ¿ë¾î] ¸é¿ª¼º¿øÀÎ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bothriocephalus anemia
    ¿­µÎÁ¶ÃæºóÇ÷
  • hookworm anemia
    ±¸ÃæºóÇ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • refractory prriod
    ºÒÀÀ±â(Ñ¢)
  • antibody-excess zone
    Ç×ü°úÀ×±¸¿ª(ù÷ô÷Φí¥Ï¡æ´)
  • antigen-excess zone
    Ç׿ø°úÀ× ±¸¿ª(ù÷ê«Î¦í¥Ï¡æ´)
  • atomic percent excess
    °ú´Ù ¿øÀÚ¹éºÐÀ²(ΦÒýê«í­ÛÝÝÂëÒ)
  • primary alkali excess
    ¿ø¹ß¼º(ê«Û¡àõ) ¾ËÄ®¸®°úÀ×(Φí¥)
  • primary carbon dioxide excess
    ¿ø¹ß¼º ÀÌ»êȭź¼Ò(ê´Û¡àõ ì£ß«ûù÷©áÈ) °úÀ×(Φí¥)
  • acquired hemolytic anemia
    "ȹµæ¿ëÇ÷¼ººóÇ÷ (üòÔðéÁúìàõÞ¸úì), ÈÄõ¿ëÇ÷¼ººóÇ÷ (ý­ô¸éÁúìàõÞ¸úì)"
  • anemia
    ºóÇ÷(Þ¸úì)
  • antipernicious anemia factor
    Ç×(ù÷)¾Ç¼ººóÇ÷(äÂàõÞ¸úì) ÀÎÀÚ(ì×í­)
  • Cooley's anemia
    "Ä𸮠ºóÇ÷(Þ¸úì), = thalassemia"
  • Fanconi's anemia
    ÆÇÄÚ´Ï ºóÇ÷(Þ¸úì)
  • hemolytic anemia
    ¿ëÇ÷ ºóÇ÷(éÁúìÞ¸úì)
  • hypochromic anemia
    Àú»ö¼Ò¼ººóÇ÷(î¸ßäáÈàõÞ¸úì)
  • pernicious anemia
    ¾Ç¼º ºóÇ÷(äÂàõÞ¸úì)
  • sickle cell anemia
    ³´¼¼Æ÷(á¬øà)ºóÇ÷(Þ¸úì)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • excess
    °úÀ×, À׿©
  • anemia
    ºóÇ÷
  • aplastic anemia
    ¹«Çü¼º¼ººóÇ÷, Àç»ýºÒ·®¼ººóÇ÷
  • deficiency anemia
    °áÇ̼ººóÇ÷
  • hemolytic anemia
    ¿ëÇ÷¼ººóÇ÷
  • hypochromic anemia
    Ç÷»ö¼Ò°¨¼Ò¼º ºóÇ÷, Àú»ö¼Ò¼ººóÇ÷
  • iron deficiency anemia
    ö°áÇ̼ººóÇ÷
  • secondary anemia
    ¼Ó¹ß¼ººóÇ÷
  • sickle-cell anemia
    °â»ó(Àû)Ç÷±¸¼ººóÇ÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
RAEB Refractory Anemia with Excess of Blasts
RAEB-T Refractory Anemia with Excess Blasts in Transformation
RAEB refractory anemia with excess blasts
RAEBiT, RAEB-T refractory anemia with excess blasts in transformation
REAB refractory anemia with excess of blasts
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
RAEB-T Refractory anemia with excess blasts in transformation
RAEB Refractory anaemia with excess of blasts
RAEB refractory anaemia with an excess of blasts
RAEB refractory anaemia with excess blasts
RAEB-t refractory anaemia with excess of blasts 'in transformation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • sideroblastic refractory anemia
    ö Àû¸ð±¸¼º ºÒÀÀ¼º ºóÇ÷
  • refractory cast
    ³»È­¼º ¸ðÇü
    ºÐÇØµÇÁö ¾Ê°í °í¿­À» °ßµô ¼ö ÀÖ´Â Àç·á·Î ¸¸µé¾îÁø ¸ðÇüÀ¸·Î¼­, ±¹¼Ò ÀÇÄ¡ ÁÖÁ¶¼ú¿¡ »ç¿ëµÉ ¶§ ÆØÃ¢ÇÏ¿© ±Ý¼ÓÀÇ ¼öÃàÀ» º¸»óÇÑ´Ù.
  • refractory investment
    ³»È­ ¸Å¸ôÁ¦, ³»È­¼º ¸Å¸ôÀç
    ³³ÂøÀ̳ª ÁÖÁ¶¿¡ »ç¿ëµÇ´Â °í¿Â¿¡ °ßµô¼ö ÀÖ´Â ¸Å¸ôÀç.
  • refractory mold
    ³»È­¼º ¸ôµå
  • antibody excess zone
    Ç×ü °úÀ׿ª
  • antigen excess
    Ç׿ø °úÀ×
    ħ°­ ¹ÝÀÀ µî ÃÖÀûºñ¿¡¼­ ¹ÝÀÀÀÌ Àß °üÂûµÇ´Â °æ¿ì Ç׿øÀÇ ¾çÀÌ Áö³ªÄ¡°Ô ¸¹À¸¸é ¹Ý´ë·Î ¹ÝÀÀÀÌ ¾àÇØÁö°í °üÂûÀÌ °¡´ÉÇÑ ¹ÝÀÀÀÌ »ý±æ ¶§±îÁöÀÇ ½Ã°£ÀÌ ±æ¾îÁø´Ù. ÀÌ¿Í °°ÀÌ Ç׿øÀÌ °úÀ×µÇ¾î ¹ÝÀÀÀÌ °üÂûµÇÁö ¾Ê°Ô µÇ´Â °æ¿ì Ç׿ø °úÀ׿¡ ÀÇÇÑ ¹ÝÀÀÀÇ ¾ïÁ¦Çϰí ÇÑ´Ù. Ç׿ø Ç×ü º¹ÇÕü´Â Ç׿ø °úÀ×ÀÎ °æ¿ì¿¡´Â °¡¿ë¼ºÀÌ µÈ´Ù.
  • creatinaemia : excess of creatine in the blood.

    creatine kinase

    Å©·¹¾ÆÆ¾ Ű³ª¾ÆÁ¦
  • excess
    °úÀ×, À׿©
  • excess chlorine
    °úÀ× ¿°¼Ò
  • excess factor
    °úÀ× ÀÎÀÚ
  • excess lactate
    °úÀ× À¯»ê, °úÀ× À¯»ê¿°
  • excess sludge
    °úÀ× ½½·¯Áö
  • excess water
    À׿© ¼öºÐ
  • zone of antigen excess
    Ç׿ø °úÀ×´ë
    ºñ±³Àû °í³óµµÀÇ Ç׿ø´ë·Î¼­ ħ°­¹ÝÀÀ¿¡¼­ °¡¿ë¼º º¹ÇÕü°¡ Çü¼ºµÇ¸ç ¹ÝÀÀÀÌ ¾ïÁ¦µÈ´Ù.
  • acute cerebral anemia
    ±Þ¼º ³ú ºóÇ÷
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
anaemia, refractory, with excess of blasts Chronic refractory anaemia with granulocytopenia, and/or thrombocytopenia. Myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells.
(12 Dec 1998)
refractory anaemia with excess blasts <haematology> A form of myelodysplasia characterised by the build up of immature white blood cells (blasts) in the bone marrow.
If the immature cells are particularly numerous it may indicate a chance of transformation to acute leukaemia and the condition is called refractory anaemia with excess blasts in transformation (RAEBt).
Acronym: RAEB
(13 Nov 1997)
anemia <haematology> Too few red blood cells in the bloodstream, resulting in insufficient oxygen to tissues and organs.
Origin: Gr. Haima = blood
(16 Dec 1997)
blasts Immature blood cells.
(12 Dec 1998)
antibody excess In a precipitation test, the presence of antibody in an amount greater than that required to combine with all of the antigen present.
(05 Mar 2000)
antigen excess In a precipitation test, the presence of uncombined antigen above that required to combine with all of the antibody; precipitation may be inhibited because the presence of excess antigen gives rise to soluble antigen-antibody complexes, in vivo the resultant antigen-antibody interaction in such an antigen excess may give rise to immune complexes, which have a potential to induce cellular damage; such injury underlies the pathologic changes seen in certain immune complex diseases.
(05 Mar 2000)
base excess A measure of metabolic alkalosis, usually predicted from the Siggaard-Andersen nomogram; the amount of strong acid that would have to be added per unit volume of whole blood to titrate it to pH 7.4 while at 37°C and at a carbon dioxide pressure of 40 mm Hg.
(05 Mar 2000)
calcium excess Overly high intake of calcium (hypercalcaemia) may cause muscle weakness and constipation, affect the conduction of electrical impulses in the heart (heart block) lead to calcium stones in the urinary tract, impair kidney function (through nephrocalcinosis), and interfere with the absorption of iron predisposing to iron deficiency. According to the National Academy of Sciences, adequate intake of calcium is 1 gram daily for both men and women. The upper limit for calcium intake is 2.5 grams daily.
(12 Dec 1998)
magnesium excess Persons with impaired kidney function should be especially careful about their magnesium intake because they can accumulate magnesium, a dangerous situation. According to the national academy of sciences, the recommended dietary allowances of magnesium are 420 milligrams per day for men and 320 milligrams per day for women. The upper limit of magnesium as supplements is 350 milligrams daily, in addition to the magnesium from food and water.
(12 Dec 1998)
convergence excess That condition in which an oesophoria or esotropia is greater for near vision than for far vision.
(05 Mar 2000)
selenium excess Too much of the mineral selenium may cause reversible changes in the hair (balding) and nails, garlic odour to the breath, intestinal distress, weakness and slower mentation (slowed mental functionning). According to the national academy of sciences, the recommended dietary allowances of selenium are 70 milligrams per day for men and 55 milligrams per day for women.
(12 Dec 1998)
negative base excess A measure of metabolic acidosis, usually predicted from the Siggaard-Andersen nomogram; the amount of strong alkali that would have to be added per unit volume of whole blood to titrate it to pH 7.4 while at 37°C and at a carbon dioxide pressure of 40 mm Hg.
(05 Mar 2000)
divergence excess exotropia Exotropia in which the strabismus is notably greater for far vision than for near vision.
(05 Mar 2000)
iodine excess Just as too little iodine can cause thyroid disease, so may prolonged intake of too much iodine also lead to the development of goiter (swelling of the thyroid gland) and hypothyroidism (abnormally low thyroid activity). Certain foods and medications contain large amounts of iodine. Examples include seaweed; iodine-rich expectorants (such as sski and lugol's solution) used in the treatment of cough, asthma, chronic pulmonary disease; and amiodarone (cardorone), an iodine-rich medication used in the control of abnormal heart rhythms (cardiac arrhythmias).
(12 Dec 1998)
iron excess Iron overload can damage the heart, liver, gonads and other organs. Iron overload is a particular risk in people who may have certain genetic conditions (haemochromatosis) sometimes without knowing it and also in people receiving recurrent blood transfusions. According to the national academy of sciences, the recommended dietary allowances of iron are 15 milligrams per day for women and 10 milligrams per day for men.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • refractory
    ´Ù·ç±â Èûµç; ³­Ä¡ÀÇ
  • refractory
    (»ç¶÷.µ¿¹° µîÀÌ)°¨´çÇÒ ¼ö ¾ø´Â;´Ù·ç±â Èûµå´Â;¼øÁ¾ÇÏÁö ¾Ê´Â;³­Ä¡ÀÇ;¿Ï°íÇÑ;(º´ µî¿¡)ÀúÇ× ÇÒ ¼ö ÀÖ´Â;º´µ¶¿¡ °¨¿°µÇÁö ¾Ê´Â;(±Ý¼Ó µîÀÌ)¿ëÇØ(ó¸®)Çϱ⠾î·Á¿î;(º®µ¹ µîÀÌ)³»È­¼ºÀÇ;³»È­ ¹°Áú;³»È­ º®µ¹;-riness
  • anemia
    ¾Ç¼ººóÇ÷
  • Fanconi's anemia
    ÆÇÄڴϺóÇ÷
  • anemia
    ºóÇ÷Áõ
  • cerebral anemia
    ³úºóÇ÷
  • pernicious anemia
    ¾Ç¼º ºóÇ÷
  • excess
    °ú´Ù(ÀÇ); ÆøÀ½(½Ä)
  • excess
    °úµµ;°ú´Ù;°úÀ×;Ãʰú;Ãʰú·®;ºÎÀýÁ¦;Áö³ªÄ§;³­Æø;ÆøÀ½Æø½Ä(excess of imports over exports ¼öÀÔ Ãʰú) a
  • excess baggage
    Á¦ÇÑ Ãʰú ¼öÇϹ°
  • excess charge
    ÁÖÂ÷ ½Ã°£ Ãʰú ¿ä±Ý
  • excess fare
    öµµÀÇ °Å¸® Ãʰú ¿ä±Ý;Ãʰú ¿ä±Ý
  • excess luggage
    =EXCESS BAGGAGE
  • excess postage
    ¿ìÇ¥ ºÎÁ· ¿ä±Ý
  • excess reserves
    (ÀºÇà)Ãʰú Áغñ±Ý
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á